Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T W Barrowcliffe

Showing results (71-80 of 159) with videos related to

Pageof 16
Sort By:
Lancet (London, England)|July 28, 1979
Major effect of prediluent in factor IX clotting assayT W Barrowcliffe, M S Tydeman, T B Kirkwood
Thrombosis and Haemostasis|December 20, 1993
Inhibitor development and activated factor VIII in concentratesT W Barrowcliffe, G Kemball-Cook, J E Tubbs
British Journal of Haematology|September 1, 1990
Factor VIII heavy chain polypeptides in plasma and concentratesG Kemball-Cook, S A Bevan, T W Barrowcliffe
Thrombosis and Haemostasis|October 31, 1984
A collaborative study designed to establish the 4th International Standard for HeparinD P Thomas, A D Curtis, T W Barrowcliffe
Lancet (London, England)|April 12, 1980
Aluminium hydroxide adsorption and factor VIII clotting assaysT W Barrowcliffe, T B Kirkwood, C R Rizza
Haemostasis|January 1, 1986
Low molecular weight heparin: a better drug?D P Thomas, T W Barrowcliffe, A D Curtis
Thrombosis and Haemostasis|December 21, 1979
In vivo recovery of factor VIII: a comparison of one-stage and two-stage assay methodsI M Nilsson, T B Kirkwood, T W Barrowcliffe
Annals of the New York Academy of Sciences|January 1, 1989
Relative efficacy of heparin and related glycosaminoglycans as antithrombotic drugsD P Thomas, R E Merton, T W Barrowcliffe
British Journal of Haematology|June 1, 1991
Proteolysis of factor VIII heavy chain polypeptides in plasma and concentratesG Kemball-Cook, S J Edwards, T W Barrowcliffe
Haemostasis|January 1, 1989
Assay discrepancies with highly purified factor VIII concentratesN J Dawson, G Kemball-Cook, T W Barrowcliffe
Pageof 16

Showing results (71-80 of 159) with videos related to

Sort By:
Pageof 16
Lancet (London, England)|July 28, 1979
Major effect of prediluent in factor IX clotting assayT W Barrowcliffe, M S Tydeman, T B Kirkwood
Thrombosis and Haemostasis|December 20, 1993
Inhibitor development and activated factor VIII in concentratesT W Barrowcliffe, G Kemball-Cook, J E Tubbs
British Journal of Haematology|September 1, 1990
Factor VIII heavy chain polypeptides in plasma and concentratesG Kemball-Cook, S A Bevan, T W Barrowcliffe
Thrombosis and Haemostasis|October 31, 1984
A collaborative study designed to establish the 4th International Standard for HeparinD P Thomas, A D Curtis, T W Barrowcliffe
Lancet (London, England)|April 12, 1980
Aluminium hydroxide adsorption and factor VIII clotting assaysT W Barrowcliffe, T B Kirkwood, C R Rizza
Haemostasis|January 1, 1986
Low molecular weight heparin: a better drug?D P Thomas, T W Barrowcliffe, A D Curtis
Thrombosis and Haemostasis|December 21, 1979
In vivo recovery of factor VIII: a comparison of one-stage and two-stage assay methodsI M Nilsson, T B Kirkwood, T W Barrowcliffe
Annals of the New York Academy of Sciences|January 1, 1989
Relative efficacy of heparin and related glycosaminoglycans as antithrombotic drugsD P Thomas, R E Merton, T W Barrowcliffe
British Journal of Haematology|June 1, 1991
Proteolysis of factor VIII heavy chain polypeptides in plasma and concentratesG Kemball-Cook, S J Edwards, T W Barrowcliffe
Haemostasis|January 1, 1989
Assay discrepancies with highly purified factor VIII concentratesN J Dawson, G Kemball-Cook, T W Barrowcliffe
Pageof 16